On the fly News and insights, exclusive to thefly.com

JNJ

Johnson & Johnson

$138.43 /

-1.66 (-1.19%)

11:50
07/12/19
07/12
11:50
07/12/19
11:50

DOJ opens criminal probe of J&J baby powder risk denials, Bloomberg reports

The Department of Justice Department is pursuing a criminal investigation into whether Johnson & Johnson lied to the public about the possible cancer risks of its talcum powder, Jef Feeley of Bloomberg reports, citing people with knowledge of the matter. A grand jury in Washington is examining documents related to what company officials knew about any carcinogens in their products, sources told Bloomberg. Shares of Johnson & Johnson are down 4% to $134.90 in midday trading.

  • 16

    Jul

  • 09

    Sep

  • 16

    Sep

JNJ Johnson & Johnson
$138.43 /

-1.66 (-1.19%)

07/12/19 Wells Fargo
Australia implant ban 'excellent news' for Establishment Labs, says Wells Fargo
07/12/19 Credit Suisse
Johnson & Johnson assumed with an Outperform at Credit Suisse
07/11/19 Jefferies
Australia implants decision a 'big positive' for Establishment, says Jefferies
07/11/19 Raymond James
Death of drug rebate rule a win for PBMs and distributors, says Raymond James

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.